Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
CA$0.03 - CA$0.10
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$9.74M |
EV | CA$20.51M |
Shares Outstanding | 162.25M |
Beta | -0.15 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 74.50% |
EPS | -144.10% |
Operating Cash Flow | - |
Free Cash Flow | 122.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -100.79% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Britannia Life Sciences Inc.
BLAB
Sector
Healthcare
Industry
Biotechnology
CEO
Shippen, Peter
Employees
Website
britannia.lifeIPO Date
2021-11-18
Headquarters
120 Adelaide Street West, Suite 2400, Toronto, Ontario, M5H 1T1, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved